Skip to main navigation menu Skip to main content Skip to site footer

Brief Report

Vol. 19 No. 1 (2021)

Assessing the appropriateness of colorectal cancer screening in very elderly women: A cross-sectional analysis

DOI
https://doi.org/10.26443/mjm.v19i1.339
Submitted
October 18, 2020
Published
2021-03-03

Abstract

The Canadian Task Force on Preventive Health Care recommends against screening for colorectal cancer after age 75. This recommendation is based in part on lag time to mortality benefit and a reduced life expectancy in the very elderly. To explore the extent to which screening for colorectal cancer is appropriately ordered in primary care, we performed a cross sectional study in women aged 80-84 at an academic family medicine clinic in Montreal. Appropriateness was assessed using a validated life expectancy calculator, with a 10-year life expectancy of >50% serving as the threshold for appropriateness. Among women 80-84 years of age under the care of a physician in 2016 (N=144), 95 fecal immunochemical tests were ordered from 2016-2019. Of these, 41 were screening tests, and 16/41 (39%; 95% CI 24% to 54%) were deemed to be inappropriate. This finding suggests a need to improve screening decisions for elderly women followed in primary care.

 

References

  1. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018 Apr 9;190(14):E422–9.
  2. Care CTF on PH. Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016 Mar 15;188(5):340–8.
  3. Lee SJ, Leipzig RM, Walter LC. “When Will it Help?” Incorporating Lagtime to Benefit into Prevention Decisions for Older Adults. JAMA. 2013 Dec 25;310(24):2609–10.
  4. Grad R, Thériault G, Singh H, Dickinson JA, Szafran O, Bell NR. Age to stop?: Appropriate screening in older patients. Can Fam Physician. 2019 Aug 1;65(8):543–8.
  5. Charlson Comorbidity Index (CCI) [Internet]. MDCalc. [cited 2020 Oct 18]. Available from: https://www.mdcalc.com/charlson-comorbidity-index-cci
  6. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries. Am J Epidemiol. 2011 Mar 15;173(6):676–82.
  7. Gapanenko K, Lam D, Parker M, D’Silva J, Johnson T. Unnecessary Care in Canada. Healthc Q Tor Ont. 2017;20(3):10–1.
  8. McAlister FA, Lin M, Bakal J, Dean S. Frequency of low-value care in Alberta, Canada: a retrospective cohort study. BMJ Qual Saf. 2018;27(5):340–6.
  9. Schoenborn NL, Massare J, Park R, Pollack CE, Choi Y, Boyd CM. Clinician Perspectives on Overscreening for Cancer in Older Adults With Limited Life Expectancy. J Am Geriatr Soc. 2020;68(7):1462–8.

Metrics

Metrics Loading ...